Skip to main content
. 2019 Mar 15;9(3):e024159. doi: 10.1136/bmjopen-2018-024159

Figure 3.

Figure 3

Facilitators to the adoption of high value practices (low molecular weight heparin for venous thromboembolism prophylaxis) and de-adoption of low value practices (albumin for fluid resuscitation). MD, medical doctor; QI, quality improvement.